In fact, APOE4 non-carriers tend to be misclassified more frequently, such that 13% of APOE4 carriers versus 37% of non-carriers with the clinical diagnosis of mild-to-moderate Alzheimer’s dementia do not meet neuropathological criteria for AD8. The gene discussed is APOE; the disease is Alzheimer disease.